Arax Advisory Partners’s LeMaitre Vascular LMAT Stock Holding History

Arax Advisory Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.5K	Sell	328 -241	-42%	-$24.7K	﹤0.01%	3642
2026 Q1	$62.1K	Buy	569 +1	+0.2%	+$95	﹤0.01%	1591
2025 Q4	$46K	Sell	568 -280	-33%	-$24.1K	﹤0.01%	1648
2025 Q3	$74.2K	Sell	848 -495	-37%	-$44.2K	﹤0.01%	1659
2025 Q2	$112K	Buy	1,343 +790	+143%	+$66K	0.01%	885
2025 Q1	$46.4K	Sell	553 -7	-1%	-$651	﹤0.01%	972
2024 Q4	$51.6K	Hold	560	–	–	﹤0.01%	890
2024 Q3	$52K	Sell	560 -74	-12%	-$6.41K	﹤0.01%	706
2024 Q2	$52.2K	Sell	634 -50	-7%	-$3.67K	0.01%	643
2024 Q1	$45.4K	Sell	684 -1	-0.1%	-$62	﹤0.01%	521
2023 Q4	$38.9K	Buy	685 +524	+325%	+$27.4K	﹤0.01%	528
2023 Q3	$8.75K	Buy	161 +1	+0.6%	+$59	﹤0.01%	751
2023 Q2	$10.8K	Hold	160	–	–	﹤0.01%	691
2023 Q1	$8.25K	Sell	160 -1	-0.6%	-$49	﹤0.01%	726
2022 Q4	$7.41K	Hold	161	–	–	﹤0.01%	696
2022 Q3	$8K	Hold	161	–	–	﹤0.01%	692
2022 Q2	$7K	Buy	161 +1	+0.6%	+$45	﹤0.01%	704
2022 Q1	$7K	Buy	160 +40	+33%	+$1.79K	﹤0.01%	706
2021 Q4	$6K	Sell	120 -42	-26%	-$2.17K	﹤0.01%	740
2021 Q3	$9K	Hold	162	–	–	﹤0.01%	661
2021 Q2	$10K	Buy	+162	New	+$8.61K	﹤0.01%	666

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Arax Advisory Partners's LMAT Position: Q2 2026 in Review

Arax Advisory Partners reduced its LeMaitre Vascular (LMAT) stake by 42% in Q2 2026, selling an estimated $24.7K and leaving 328 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3642.

Arax Advisory Partners first reported a position in LMAT in Q2 2021 and has held it in 21 quarters since. The position peaked at $112K in Q2 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Arax Advisory Partners held 328 shares of LeMaitre Vascular worth $31.5K as of Q2 2026.
Arax Advisory Partners sold 241 LeMaitre Vascular shares in Q2 2026, an estimated $24.7K.
LeMaitre Vascular made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3642 holding.
Arax Advisory Partners first reported a position in LeMaitre Vascular in Q2 2021 and has held it in 21 quarters since.
Arax Advisory Partners's LeMaitre Vascular position peaked at $112K in Q2 2025.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.